Elevated Levels of Urinary Biomarkers TIMP-2 and IGFBP-7 Predict Acute Kidney Injury in Neonates after Congenital

Michelle Ramírez1, Sujata Chakravarti1, Melissa Busovsky-McNeal1

  • 1Pediatric Cardiac Intensive Care, NYU Hassenfeld Children's Hospital, New York, United States.

Insights

Urinary biomarkers tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP-7) effectively identify acute kidney injury (AKI) in neonates post-congenital heart surgery. Elevated levels 24 hours after cardiopulmonary bypass predict AKI development.

Area of Science:

  • Nephrology
  • Pediatric Cardiology
  • Biomarker Discovery

Background:

  • Acute kidney injury (AKI) is a significant complication following congenital heart surgery (CHS).
  • Early and accurate identification of AKI is crucial for improving patient outcomes.
  • Existing diagnostic methods may have limitations in the neonatal population.

Purpose of the Study:

  • To evaluate the utility of urine biomarkers tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP-7) for AKI detection in neonates undergoing CHS.
  • To assess the predictive value of the combined biomarker panel [TIMP-2*IGFBP-7] for AKI.
  • To correlate biomarker levels with AKI severity based on Acute Kidney Injury Network (AKIN) criteria.

Main Methods:

  • Prospective, single-center study involving neonates undergoing CHS with cardiopulmonary bypass (CPB).
  • Urine samples collected pre-surgery and at 6, 12, 24, and 96 hours post-CPB.
  • Analysis of urinary [TIMP-2*IGFBP-7] using NephroCheck and evaluation by AKIN criteria.
  • Statistical analysis including Wilcoxon rank sum tests and receiver operating characteristic (ROC) curves.

Main Results:

  • Out of 36 neonates, 19 (53%) developed AKI post-operatively (13 stage 1, 5 stage 2, 1 stage 3).
  • No patients required renal replacement therapy.
  • Significantly higher urinary [TIMP-2*IGFBP-7] levels were observed in patients with AKI compared to those without AKI at 24 hours post-CPB (1.1 vs. 0.27 [ng/mL]²/1,000; adj-p=0.0019).

Conclusions:

  • Urinary [TIMP-2*IGFBP-7] is a valuable and sensitive biomarker for predicting AKI in neonates after CHS.
  • The combined biomarker panel demonstrates strong predictive performance for AKI at 24 hours post-CPB.
  • This non-invasive method can aid in early AKI diagnosis and management in this vulnerable population.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
56
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
68
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
69
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
83
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
55
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44